NASDAQ:CMMB

Chemomab Therapeutics Stock Forecast

etoro logo Buy CMMB
*Your capital is at risk
$1.52
+0 (+0%)
At Close: Jul 16, 2026
AI Analysis AI Analysis of CMMB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CMMB to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Weaker technical forecast for Chemomab Therapeutics Ltd. as stock downgraded to Sell Candidate
(Updated on Jul 16, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 16, 2026

No changes to the price of Chemomab Therapeutics Ltd. stock on the last trading day (Thursday, 16th Jul 2026). During the last trading day the stock fluctuated 6.00% from a day low at $1.50 to a day high of $1.59. The price has fallen in 6 of the last 10 days and is down by -10.59% for this period.

The stock has broken the very wide and weak rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $1.52. A reaction back to this level may hold a second chance to get out before further falls.

CMMB Signals & Forecast

There are mixed signals in the stock today. The Chemomab Therapeutics Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.68 and $1.76. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Wednesday, July 15, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point".

Support, Risk & Stop-loss for Chemomab Therapeutics Ltd. stock

Chemomab Therapeutics Ltd. finds support from accumulated volume at $1.51 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0900 between high and low, or 6.00%. For the last week, the stock has had daily average volatility of 10.69%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CMMB) For The Upcoming Trading Day Of Friday 17th

For the upcoming trading day on Friday, 17th we expect Chemomab Therapeutics Ltd. to open at $1.54, and during the day (based on 14 day Average True Range), to move between $1.41 and $1.63, which gives a possible trading interval of +/-$0.229 (+/-16.32%) up or down from last closing price. If Chemomab Therapeutics Ltd. takes out the full calculated possible swing range there will be an estimated 16.32% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.51 (0.99%) than the resistance at $1.65 (8.55%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Chemomab Therapeutics Ltd. stock A Buy?

Chemomab Therapeutics Ltd. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -4.219 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 17, 2026 - $1.54 ( 1.10%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CMMB Performance

Trading levels for CMMB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.63 7.02%
R2 1.59 4.76%
R1 1.57 3.36%
Price 1.52
S1 1.50 -1.17%
S2 1.48 -2.56%
S3 1.45 -4.82%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.83 20.39%
R2 1.74 14.47%
R1 1.65 8.55%
Price 1.52
S1 1.51 -0.99%
S2 1.50 -1.32%
S3 1.48 -2.96%

FAQ

What is the symbol for Chemomab Therapeutics Ltd. Stock and on which exchange is it traded?
The symbol for Chemomab Therapeutics Ltd. is CMMB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Chemomab Therapeutics Ltd. Stock?
Chemomab Therapeutics Ltd. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy Chemomab Therapeutics Ltd. Stock?
Chemomab Therapeutics Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Chemomab Therapeutics Ltd. Stock.

What's the current price of Chemomab Therapeutics Ltd. Stock?
As of the end of day on the Jul 16, 2026, the price of an Chemomab Therapeutics Ltd. (CMMB) share was $1.52.

What is the 52-week high and low for Chemomab Therapeutics Ltd. Stock?
The 52-week high for Chemomab Therapeutics Ltd. Stock is $3.86 and the 52-week low is $0.85.

What is the market capitalization of Chemomab Therapeutics Ltd. Stock?
As of the Jul 16, 2026, the market capitalization of Chemomab Therapeutics Ltd. is 9.356M.

When is the next earnings date for Chemomab Therapeutics Ltd.?
The upcoming earnings date for Chemomab Therapeutics Ltd. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT CHEMOMAB THERAPEUTICS LTD.
Chemomab Therapeutics
Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and cha...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
3.06% Jul 13
SRPT
$17.02
1.23% Jun 29
NMRK
$15.02
5.86% Jun 24
X
XMAX
$8.34
2.28% Jun 24
JLL
$299.78
12.03% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE